R. Moss and C. Lee, Current and emerging therapies for the treatment of pancreatic cancer, Onco Targets Ther, vol.3, pp.111-127, 2010.

S. Jones, X. Zhang, D. Parsons, J. Lin, R. Leary et al., Core signaling pathways in human pancreatic cancers revealed by global genomic analyses, Science, issue.5897, pp.3211801-1806, 2008.

H. Wong and N. Lemoine, Novel therapies for pancreatic cancer: setbacks and progress, Future Oncol, vol.6, issue.7, pp.1061-1064, 2010.

M. Bhattacharyya and N. Lemoine, Gene therapy developments for pancreatic cancer, Best Pract Res Clin Gastroenterol, vol.20, issue.2, pp.285-298, 2006.
DOI : 10.1016/j.bpg.2005.10.004

S. Bhaumik, Advances in imaging gene-directed enzyme prodrug therapy, Curr Pharm Biotechnol, vol.2011, issue.124, pp.497-507

A. Dimou, K. Syrigos, and M. Saif, Novel agents in the management of pancreatic adenocarcinoma: phase I studies. Highlights from the, ASCO Gastrointestinal Cancers Symposium, vol.12, issue.2, pp.114-116, 2011.

R. Hase, M. Miyamoto, H. Uehara, M. Kadoya, Y. Ebihara et al., Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice, Clin Cancer Res, vol.24, issue.1, pp.118737-8744, 2005.

G. Saraga, A. Mafficini, P. Ghaneh, C. Sorio, and E. Costello, Both HIV-and EIAVbased lentiviral vectors mediate gene delivery to pancreatic cancer cells and human pancreatic primary patient xenografts, Cancer Gene Ther, vol.14, issue.9, pp.781-790, 2007.
DOI : 10.1038/sj.cgt.7701066

E. Ravet, H. Lulka, F. Gross, L. Casteilla, L. Buscail et al., Using lentiviral vectors for efficient pancreatic cancer gene therapy, Cancer Gene Ther, vol.17, issue.5, pp.315-324, 2010.
DOI : 10.1038/cgt.2009.79
URL : https://hal.archives-ouvertes.fr/inserm-00480870

K. Ohno, K. Sawai, Y. Iijima, B. Levin, and D. Meruelo, Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A, Nat Biotechnol, vol.15, issue.8, pp.763-767, 1997.

Y. Iijima, K. Ohno, H. Ikeda, K. Sawai, B. Levin et al., Cell-specific targeting of a thymidine kinase/ganciclovir gene therapy system using a recombinant Sindbis virus vector, Int J Cancer, vol.80, issue.1, pp.110-118, 1999.

K. Morizono, G. Bristol, Y. Xie, S. Kung, and I. Chen, Antibody-directed targeting of retroviral vectors via cell surface antigens, J Virol, issue.17, pp.758016-8020, 2001.

N. Pariente, K. Morizono, M. Virk, F. Petrigliano, R. Reiter et al., A novel dual-targeted lentiviral vector leads to specific transduction of prostate cancer bone metastases in vivo after systemic administration, Mol Ther, issue.11, pp.151973-1981, 2007.

K. Zhang, M. Moussavi, C. Kim, E. Chow, I. Chen et al., Lentiviruses with trastuzumab bound to their envelopes can target and kill prostate cancer cells, Cancer Gene Ther, issue.11, pp.16820-831, 2009.
DOI : 10.1038/cgt.2009.28

K. Zhang, C. Kim, E. Chow, I. Chen, W. Jia et al., Targeting trastuzumab-resistant breast cancer cells with a lentivirus engineered to bind antibodies that recognize HER-2, Breast Cancer Res Treat, vol.125, issue.1, pp.89-97, 2011.

H. Harsha, K. Kandasamy, P. Ranganathan, R. S. Ramabadran, S. Gollapudi et al., Acompendiumof potential biomarkers of pancreatic cancer, PLoS Med, vol.6, issue.4, p.1000046, 2009.

U. Sahin, M. Koslowski, K. Dhaene, D. Usener, G. Brandenburg et al., Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development, Clin Cancer Res, issue.23, pp.147624-7634, 2008.

P. Chaturvedi, A. Singh, N. Moniaux, S. Senapati, S. Chakraborty et al., MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins, Mol Cancer Res, vol.5, issue.4, pp.309-320, 2007.

M. Wente, A. Jain, E. Kono, P. Berberat, T. Giese et al., Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer, Pancreas, issue.2, pp.31119-125, 2005.

L. Naldini, U. Blomer, P. Gallay, D. Ory, R. Mulligan et al., In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector, Science, issue.5259, pp.272263-267, 1996.

P. Argani, C. Rosty, R. Reiter, R. Wilentz, S. Murugesan et al., Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma, Cancer Res, issue.11, pp.614320-4324, 2001.

J. Hecht, R. Bedford, J. Abbruzzese, S. Lahoti, T. Reid et al., A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma, Clin Cancer Res, vol.9, issue.2, pp.555-561, 2003.

L. Yang, L. Bailey, D. Baltimore, and P. Wang, Targeting lentiviral vectors to specific cell types in vivo, Proc Natl Acad Sci, vol.103, issue.31, pp.11479-11484, 2006.

K. Morizono, Y. Xie, G. Helguera, T. Daniels, T. Lane et al., A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide, J Gene Med, issue.8, pp.11655-663, 2009.

E. Robert-richard, E. Richard, P. Malik, C. Ged, H. De-verneuil et al., Murine retroviral but not human cellular promoters induce in vivo erythroid-specific deregulation that can be partially prevented by insulators, Mol Ther, vol.15, issue.1, pp.173-182, 2007.